483
Steris CorporationFDA 483 - Steris Corporation - March 31, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Carefusion 2200 Inc in Saint Louis, MO, revealed a significant lapse in quality system procedures. The firm failed to establish procedures for finished device acceptance, leading to products not being properly identified or quarantined. This indicates a moderate compliance issue related to device control.
Open in Dashboard
ID · 9ae203c3-7b01-4f91-8c77-9527180af18d